Aspire Biopharma director Ajjarapu resigns from board

Aspire Biopharma Holdings Inc. (NASDAQ: ASBP) announced that director Surendra Ajjarapu resigned from the company's board effective immediately on January 7, 2026.

The company stated that Ajjarapu's resignation was not due to any disagreement with the company, the board of directors, or management, according to a press release statement.

Ajjarapu notified the board of directors of his intention to step down from his director role. No additional details regarding the resignation were provided in the announcement.

You May Also Be Interested In

• Virtus Investment Partners names Jack Boyce to its board
• LiveRamp shrinks board to six directors after resignation
• Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders